The T-SPOT®.COVID test is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, specifically the T cell response. It has been developed using the standarised T-SPOT Technology.

The T-SPOT.COVID test is CE marked and has been submitted to the FDA for Emergency use authorisation.

Visit our T-SPOT.COVID website